← Back to Search

Alpha-Glucosidase Inhibitor

Acarbose Tablets 50mg for Drug Tolerance

Phase 4
Waitlist Available
Research Sponsored by AgelessRx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 minutes per phase, recorded on 4 separate occasions over 2 weeks.
Awards & highlights

Summary

This trial looks at whether taking acarbose can help reduce glucose spikes after eating carbohydrates in healthy individuals.

Eligible Conditions
  • Drug Tolerance
  • Side Effects
  • Hyperglycemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes per phase, recorded on 4 separate occasions over 2 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 minutes per phase, recorded on 4 separate occasions over 2 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Monophasic glucose response
Secondary study objectives
Tolerability of Side Effect

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm BExperimental Treatment1 Intervention
Group II: Arm AExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acarbose Tablets 50mg
2022
Completed Phase 4
~20

Find a Location

Who is running the clinical trial?

AgelessRxLead Sponsor
6 Previous Clinical Trials
262 Total Patients Enrolled
~5 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top